semaglutide cv outcomes and Cardiovascular in Patients with Type 2 Diabetes Semaglutide and cardiovascular outcomes by

Suffered sudden vision loss or blindness (NAION) after using brand-name Ozempic or Wegovy

GLP-1 receptor agonist therapy, including semaglutide and tirzepatide, offers a physician-supervised path to meaningful, sustainable weight loss backed by clinical science.

Learn More About Retatrutide

A heart attack can feel a lot like heartburn, indigestion, or acid reflux

Learn how your medspas can legally prescribe and sell Ozempic, and ensure clients' safety for efficient weight loss procedures.

I farmaci per la gestione del diabete sono sempre pi utilizzati anche per la perdita di peso, ma gli studi clinici dimostrano che i pazienti ne interrompono l'assunzione dopo poco tempo